EHA/X
Aug 27, 2026, 00:14
Join EHA ReCon 2027 in Malta – Explore RNA Biology to Therapeutics
European Hematology Association (EHA) shared a post on X:
“Dive into the world of RNA from biology to therapeutics in hematology at the EHA Research Conference 2027.
Registration and abstract submission are now open for the fifth EHA Research Conference (ReCon2027) titled ‘RNA Matters:
From basic biology to therapeutics in hematology.’ Taking place from March 22-25, 2027 in St Pauls Bay, Malta, ReCon2027 is a dedicated space for basic and translational researchers in hematology to connect, exchange new developments, and present their work.
Register today or submit your abstract here.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE